tru Independence’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7,163
Closed -$201K 109
2026
Q1
$201K Buy
+7,163
New +$191K 0.1% 101
2021
Q3
Sell
-136,253
Closed -$5.33M 304
2021
Q2
$5.33M Sell
136,253
-37
-0% -$1.44K 1.57% 34
2021
Q1
$4.94M Sell
136,290
-1,997
-1% -$70.9K 0.93% 44
2020
Q4
$5.09K Sell
138,287
-5,388
-4% -$198K 0.01% 287
2020
Q3
$5M Sell
143,675
-85,989
-37% -$3.01M 1.42% 25
2020
Q2
$7.13K Buy
229,664
+3,886
+2% +$132K 1.03% 12
2020
Q1
$6.99K Sell
225,778
-126,454
-36% -$4.31M 1.14% 14
2019
Q4
$11.7M Buy
+352,232
New +$12.5M 1.68% 9

Other funds holding PFE

tru Independence's PFE Position: Q2 2026 in Review

tru Independence sold out of Pfizer (PFE) in Q2 2026, closing a stake of 7,163 shares — an estimated $201K sold.

tru Independence first reported a position in PFE in Q4 2019 and held it in 8 quarters. The position peaked at $11.7M in Q4 2019. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • tru Independence reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • tru Independence sold 7,163 Pfizer shares in Q2 2026, an estimated $201K.
  • tru Independence first reported a position in Pfizer in Q4 2019 and held it in 8 quarters.
  • tru Independence's Pfizer position peaked at $11.7M in Q4 2019.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on tru Independence's 13F filing for Q2 2026, filed 10 Aug 2026.